Adrián Chrastina

1.1k total citations
22 papers, 908 citations indexed

About

Adrián Chrastina is a scholar working on Molecular Biology, Toxicology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Adrián Chrastina has authored 22 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Toxicology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Adrián Chrastina's work include Bioactive Compounds and Antitumor Agents (5 papers), Enzyme function and inhibition (4 papers) and Cell Adhesion Molecules Research (4 papers). Adrián Chrastina is often cited by papers focused on Bioactive Compounds and Antitumor Agents (5 papers), Enzyme function and inhibition (4 papers) and Cell Adhesion Molecules Research (4 papers). Adrián Chrastina collaborates with scholars based in United States, Slovakia and Belgium. Adrián Chrastina's co-authors include Jan E. Schnitzer, Kerri A. Massey, Per Borgström, Silvia Pastoreková, Phil Oh, Jacqueline E. Testa, Milota Kaluzová, Jaromı́r Pastorek, Štefan Kaluz and Halina Witkiewicz and has published in prestigious journals such as Journal of Biological Chemistry, Nature Biotechnology and PLoS ONE.

In The Last Decade

Adrián Chrastina

22 papers receiving 881 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adrián Chrastina United States 14 510 206 180 161 120 22 908
Xiuquan Luo United States 16 581 1.1× 158 0.8× 204 1.1× 167 1.0× 122 1.0× 22 1.0k
Urarika Luesakul Thailand 9 378 0.7× 188 0.9× 198 1.1× 160 1.0× 53 0.4× 9 940
Qian Guo China 14 710 1.4× 68 0.3× 109 0.6× 140 0.9× 100 0.8× 43 994
Sriram S. Shanmugavelandy United States 17 542 1.1× 210 1.0× 363 2.0× 114 0.7× 88 0.7× 21 1.0k
Hebe Durán Argentina 15 412 0.8× 85 0.4× 115 0.6× 132 0.8× 58 0.5× 42 795
Agnieszka Marczak Poland 19 593 1.2× 128 0.6× 110 0.6× 137 0.9× 83 0.7× 87 1.1k
Aditya Ganju United States 14 595 1.2× 256 1.2× 165 0.9× 273 1.7× 40 0.3× 20 1.1k
Jichuang Wang China 24 692 1.4× 106 0.5× 173 1.0× 198 1.2× 63 0.5× 42 1.2k
Robert A. Falconer United Kingdom 19 655 1.3× 140 0.7× 157 0.9× 127 0.8× 63 0.5× 60 1.1k
Krishnendu Pal United States 20 607 1.2× 156 0.8× 182 1.0× 180 1.1× 59 0.5× 34 1.2k

Countries citing papers authored by Adrián Chrastina

Since Specialization
Citations

This map shows the geographic impact of Adrián Chrastina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrián Chrastina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrián Chrastina more than expected).

Fields of papers citing papers by Adrián Chrastina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrián Chrastina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrián Chrastina. The network helps show where Adrián Chrastina may publish in the future.

Co-authorship network of co-authors of Adrián Chrastina

This figure shows the co-authorship network connecting the top 25 collaborators of Adrián Chrastina. A scholar is included among the top collaborators of Adrián Chrastina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrián Chrastina. Adrián Chrastina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nayak, Tapas R., Adrián Chrastina, J. L. Valencia, et al.. (2024). Rapid precision targeting of nanoparticles to lung via caveolae pumping system in endothelium. Nature Nanotechnology. 20(1). 144–155. 13 indexed citations
2.
Narayanapillai, Sreekanth C., Michael D Levin, Jim Koziol, et al.. (2022). Targeting caveolae to pump bispecific antibody to TGF-β into diseased lungs enables ultra-low dose therapeutic efficacy. PLoS ONE. 17(11). e0276462–e0276462. 7 indexed citations
3.
Chrastina, Adrián, John Welsh, Per Borgström, & Véronique Baron. (2022). Propylene Glycol Caprylate‐Based Nanoemulsion Formulation of Plumbagin: Development and Characterization of Anticancer Activity. BioMed Research International. 2022(1). 3549061–3549061. 8 indexed citations
4.
Chrastina, Adrián, John Welsh, Gaëlle Rondeau, et al.. (2020). Plumbagin‐Serum Albumin Interaction: Spectral, Electrochemical, Structure‐Binding Analysis, Antiproliferative and Cell Signaling Aspects with Implications for Anticancer Therapy. ChemMedChem. 15(14). 1338–1347. 8 indexed citations
5.
Rondeau, Gaëlle, et al.. (2018). Differential gene expression induced by anti-cancer agent plumbagin is mediated by androgen receptor in prostate cancer cells. Scientific Reports. 8(1). 2694–2694. 19 indexed citations
6.
Abedinpour, Parisa, Véronique Baron, Adrián Chrastina, et al.. (2017). Plumbagin improves the efficacy of androgen deprivation therapy in prostate cancer: A pre‐clinical study. The Prostate. 77(16). 1550–1562. 29 indexed citations
7.
Chrastina, Adrián, Péter Pokreisz, & Jan E. Schnitzer. (2013). Experimental model of transthoracic, vascular-targeted, photodynamically induced myocardial infarction. American Journal of Physiology-Heart and Circulatory Physiology. 306(2). H270–H278. 12 indexed citations
8.
Abedinpour, Parisa, Véronique Baron, Adrián Chrastina, John Welsh, & Per Borgström. (2012). The combination of plumbagin with androgen withdrawal causes profound regression of prostate tumors in vivo. The Prostate. 73(5). 489–499. 16 indexed citations
9.
Chrastina, Adrián & Jan E. Schnitzer. (2011). Laser-targeted photosensitizer-induced lung injury: Noninvasive rat model of pulmonary infarction. Experimental Lung Research. 38(1). 1–8. 2 indexed citations
10.
Chrastina, Adrián, Kerri A. Massey, & Jan E. Schnitzer. (2011). Overcomingin vivobarriers to targeted nanodelivery. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 3(4). 421–437. 147 indexed citations
11.
Chrastina, Adrián, Philippe Valadon, Kerri A. Massey, & Jan E. Schnitzer. (2010). Lung Vascular Targeting Using Antibody to Aminopeptidase P: CT-SPECT Imaging, Biodistribution and Pharmacokinetic Analysis. Journal of Vascular Research. 47(6). 531–543. 41 indexed citations
12.
Valadon, Philippe, Malgorzata Czarny, Noelle M. Griffin, et al.. (2009). Designed Auto-assembly of Nanostreptabodies for Rapid Tissue-specific Targeting in Vivo. Journal of Biological Chemistry. 285(1). 713–722. 21 indexed citations
13.
Testa, Jacqueline E., Adrián Chrastina, Yan Li, Phil Oh, & Jan E. Schnitzer. (2009). Ubiquitous yet Distinct Expression of Podocalyxin on Vascular Surfaces in Normal and Tumor Tissues in the Rat. Journal of Vascular Research. 46(4). 311–324. 13 indexed citations
14.
Testa, Jacqueline E., Adrián Chrastina, Phil Oh, et al.. (2009). Immunotargeting and cloning of two CD34 variants exhibiting restricted expression in adult rat endothelia in vivo. American Journal of Physiology-Lung Cellular and Molecular Physiology. 297(2). L251–L262. 20 indexed citations
15.
Oh, Phil, Per Borgström, Halina Witkiewicz, et al.. (2007). Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nature Biotechnology. 25(3). 327–337. 242 indexed citations
16.
Chrastina, Adrián, et al.. (2005). Micelles from Poly(ethylene glycol)–Phosphatidyl Ethanolamine Conjugates (Peg-Pe) as Pharmaceutical Nanocarriers for Poorly Soluble Drug Camptothecin. Journal of Biomedical Nanotechnology. 1(2). 190–195. 23 indexed citations
17.
Chrastina, Adrián, J Závada, Seppo Parkkila, et al.. (2003). Biodistribution and pharmacokinetics of 125I‐labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma. International Journal of Cancer. 105(6). 873–881. 81 indexed citations
18.
Chrastina, Adrián, Silvia Pastoreková, & Jaromı́r Pastorek. (2003). Immunotargeting of human cervical carcinoma xenograft expressing CA IX tumor-associated antigen by 125I-labeled M75 monoclonal antibody.. PubMed. 50(1). 13–21. 22 indexed citations
19.
Kaluz, Štefan, Milota Kaluzová, Adrián Chrastina, et al.. (2002). Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase.. PubMed. 62(15). 4469–77. 126 indexed citations
20.
Šajbidor, J., et al.. (1994). Effect of salt stress on fatty acid alterations in some strains of Dipodascopsis and Dipodascus spp.. World Journal of Microbiology and Biotechnology. 10(2). 184–186. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiuquan Luo Breakdown of academic impact, for papers by Urarika Luesakul Breakdown of academic impact, for papers by Qian Guo Breakdown of academic impact, for papers by Sriram S. Shanmugavelandy Breakdown of academic impact, for papers by Hebe Durán Breakdown of academic impact, for papers by Agnieszka Marczak Breakdown of academic impact, for papers by Aditya Ganju Breakdown of academic impact, for papers by Jichuang Wang Breakdown of academic impact, for papers by Robert A. Falconer Breakdown of academic impact, for papers by Krishnendu Pal
Rankless by CCL
2026